Dr. Christina Rångemark Åkerman is a Senior Advisor of ICHOM and Senior Institute Associate at the Institute for Strategy and Competitiveness (ISC) at Harvard Business School. Between 2014-2018 she served as the President of ICHOM, where she established collaborations with a number of the world leading regulatory and policy-making institutions, doubled its team and professionalized its operations. Between 2008 and 2014, she served as Director General for the Medical Products Agency (MPA) in Sweden, a national agency employing approximately 750 people and under the aegis of the Swedish Ministry of Health and Social Affairs. During this period, she was also a Member of the Board of the European Medicines Agency (EMA), which is responsible for the scientific evaluation of medicines for use in the European Union. Before her position with MPA, Christina served as Vice President Medical of AstraZeneca Sweden as well as Marketing Company President of AstraZeneca Philippines. She has also been working chair of start-up companies and on the Board of Fouriertransform, a Swedish state-owned venture capital company. Christina received her medical degree from the University of Linköping. She wrote her doctoral thesis in Clinical Physiology and is a specialist in Clinical Pharmacology. She has an Executive MBA in General Management from the Stockholm School of Economics.